DOD Multiple Sclerosis Clinical Trial Award


Funding Opportunity ID:333436
Opportunity Number:W81XWH-21-MSRP-CTA
Opportunity Title:DOD Multiple Sclerosis Clinical Trial Award
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Category of Funding Activity:Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s):12.420
Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code:DOD-AMRAA
Agency Name:Department of Defense
Dept. of the Army — USAMRAA
Posted Date:May 10, 2021
Close Date:Oct 01, 2021
Last Updated Date:May 10, 2021
Award Ceiling:$0
Award Floor:$0
Estimated Total Program Funding:$8,000,000
Expected Number of Awards:3
Description:The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0), to demonstrate feasibility or inform the design of more advanced trials, through larger-scale phase 1 or phase 2 trials to determine safety or efficacy in relevant patient populations.

Visit the Official Webpage For More Details on DOD Multiple Sclerosis Clinical Trial Award


Please enter your comment!
Please enter your name here